Glitaray 1 Tablet contains Glimepiride 1 mg, an oral hypoglycemic agent belonging to the sulfonylurea class, primarily indicated for the management of type 2 diabetes mellitus. Glimepiride acts by stimulating pancreatic beta cells to release insulin, thereby reducing blood glucose levels. It is typically prescribed as an adjunct to diet and exercise when glycemic control is not adequately achieved through lifestyle modifications alone. Glitaray 1 Tablet helps improve glycemic control by enhancing insulin secretion and increasing peripheral glucose uptake. The medication is administered once daily, preferably with breakfast, to optimize efficacy and minimize the risk of hypoglycemia. Patients should adhere to prescribed dosages and regularly monitor blood glucose levels to avoid complications such as hypoglycemia or hyperglycemia. Common side effects may include mild hypoglycemia, nausea, dizziness, or gastrointestinal discomfort. Caution is advised in patients with hepatic or renal impairment, and it should be used cautiously in elderly patients. Glitaray is contraindicated in type 1 diabetes, diabetic ketoacidosis, and hypersensitivity to sulfonylureas. Regular follow-up with healthcare providers is essential to assess therapeutic response and adjust dosage accordingly. This medication should be used as part of a comprehensive diabetes management plan, including diet, exercise, and lifestyle modifications.

Dosage & How to Use